Parisa Shiri Aghbash

603 total citations
31 papers, 410 citations indexed

About

Parisa Shiri Aghbash is a scholar working on Infectious Diseases, Epidemiology and Immunology. According to data from OpenAlex, Parisa Shiri Aghbash has authored 31 papers receiving a total of 410 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Infectious Diseases, 11 papers in Epidemiology and 10 papers in Immunology. Recurrent topics in Parisa Shiri Aghbash's work include COVID-19 Clinical Research Studies (11 papers), SARS-CoV-2 and COVID-19 Research (7 papers) and Cervical Cancer and HPV Research (5 papers). Parisa Shiri Aghbash is often cited by papers focused on COVID-19 Clinical Research Studies (11 papers), SARS-CoV-2 and COVID-19 Research (7 papers) and Cervical Cancer and HPV Research (5 papers). Parisa Shiri Aghbash collaborates with scholars based in Iran, United States and Iraq. Parisa Shiri Aghbash's co-authors include Hossein Bannazadeh Baghi, Ali Shamekh, Taher Entezari‐Maleki, Javid Sadri Nahand, Nima Hemmat, Milad Shirvaliloo, Abolfazl Jafari-Sales, Mohammad Yousef Memar, Vahdat Poortahmasebi and Ahad Mokhtarzadeh and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gene and Life Sciences.

In The Last Decade

Parisa Shiri Aghbash

29 papers receiving 398 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Parisa Shiri Aghbash Iran 11 191 132 103 82 67 31 410
Santhamani Ramasamy United States 9 220 1.2× 87 0.7× 126 1.2× 82 1.0× 84 1.3× 25 418
Alireza Tabibzadeh Iran 13 223 1.2× 92 0.7× 181 1.8× 59 0.7× 73 1.1× 44 544
Yan‐Mei Jiao China 13 164 0.9× 94 0.7× 83 0.8× 167 2.0× 37 0.6× 48 425
Vasiliki Triantafyllia Greece 6 359 1.9× 203 1.5× 164 1.6× 348 4.2× 139 2.1× 8 730
Uffe Vest Schneider Denmark 13 147 0.8× 146 1.1× 99 1.0× 34 0.4× 20 0.3× 31 411
Paulina Nowak Poland 5 296 1.5× 64 0.5× 103 1.0× 42 0.5× 42 0.6× 6 429
Anping Ni China 8 204 1.1× 79 0.6× 47 0.5× 53 0.6× 50 0.7× 20 324
Mario Tönnies Germany 9 125 0.7× 236 1.8× 101 1.0× 119 1.5× 9 0.1× 16 496
Céline Pellaton Switzerland 12 279 1.5× 60 0.5× 99 1.0× 201 2.5× 40 0.6× 20 654
Juliana Gil Melgaço Brazil 12 196 1.0× 266 2.0× 119 1.2× 188 2.3× 13 0.2× 28 659

Countries citing papers authored by Parisa Shiri Aghbash

Since Specialization
Citations

This map shows the geographic impact of Parisa Shiri Aghbash's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Parisa Shiri Aghbash with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Parisa Shiri Aghbash more than expected).

Fields of papers citing papers by Parisa Shiri Aghbash

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Parisa Shiri Aghbash. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Parisa Shiri Aghbash. The network helps show where Parisa Shiri Aghbash may publish in the future.

Co-authorship network of co-authors of Parisa Shiri Aghbash

This figure shows the co-authorship network connecting the top 25 collaborators of Parisa Shiri Aghbash. A scholar is included among the top collaborators of Parisa Shiri Aghbash based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Parisa Shiri Aghbash. Parisa Shiri Aghbash is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Aghbash, Parisa Shiri, et al.. (2024). Coinfection of EBV with other pathogens: a narrative review. SHILAP Revista de lepidopterología. 4. 5 indexed citations
2.
3.
4.
5.
Aghbash, Parisa Shiri, et al.. (2024). The role of immune cells and inflammasomes in Modulating cytokine responses in HPV-Related cervical cancer. International Immunopharmacology. 145. 113625–113625. 4 indexed citations
6.
Nahand, Javid Sadri, Arash Salmaninejad, Hamed Mirzaei, et al.. (2023). PBMC MicroRNAs: Promising Biomarkers for the Differential Diagnosis of COVID-19 Patients with Abnormal Coagulation Indices. Current Microbiology. 80(8). 248–248. 9 indexed citations
7.
Aghbash, Parisa Shiri, et al.. (2023). SARS-CoV-2-associated organs failure and inflammation: a focus on the role of cellular and viral microRNAs. Virology Journal. 20(1). 179–179. 9 indexed citations
8.
Aghbash, Parisa Shiri, et al.. (2023). A comprehensive review of COVID-19 symptoms and treatments in the setting of autoimmune diseases. Virology Journal. 20(1). 1–1. 12 indexed citations
9.
Aghbash, Parisa Shiri, et al.. (2023). Beyond the Virus: Exploring Coinfections in the COVID-19 Pandemic. The Open Microbiology Journal. 17(1). 2 indexed citations
10.
Aghbash, Parisa Shiri, et al.. (2023). siRNA-E6 sensitizes HPV-16-related cervical cancer through Oxaliplatin: an in vitro study on anti-cancer combination therapy. European journal of medical research. 28(1). 42–42. 16 indexed citations
11.
Aghbash, Parisa Shiri, et al.. (2023). Dynamic alterations in white blood cell counts and SARS-CoV-2 shedding in saliva: an infection predictor parameter. Frontiers in Medicine. 10. 1208928–1208928. 7 indexed citations
12.
Aghbash, Parisa Shiri, et al.. (2023). Immune-checkpoint expression in antigen-presenting cells (APCs) of cytomegaloviruses infection after transplantation: as a diagnostic biomarker. Archives of Microbiology. 205(8). 280–280. 2 indexed citations
13.
Aghbash, Parisa Shiri, et al.. (2022). The effect of Wnt/β-catenin signaling on PD-1/PDL-1 axis in HPV-related cervical cancer. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 30(3). 99–116. 19 indexed citations
14.
Memar, Mohammad Yousef, Abolfazl Jafari-Sales, Ahad Bazmani, et al.. (2022). The Effect of Oncogene Proteins of Human Papillomaviruses on Apoptosis Pathways in Prostate Cancer. ONCOLOGIE. 24(2). 227–245. 15 indexed citations
15.
Aghbash, Parisa Shiri, Ali Shamekh, Taher Entezari‐Maleki, et al.. (2022). SARS-CoV-2: Receptor and Co-receptor Tropism Probability. Current Microbiology. 79(5). 133–133. 48 indexed citations
16.
Ghanbari, Elham, et al.. (2022). Severe acute respiratory syndrome coronavirus 2 infection: Role of interleukin-6 and the inflammatory cascade. World Journal of Virology. 11(3). 113–128. 9 indexed citations
17.
Aghbash, Parisa Shiri, et al.. (2022). Monoclonal antibodies in cervical malignancy-related HPV. Frontiers in Oncology. 12. 904790–904790. 14 indexed citations
18.
Aghbash, Parisa Shiri, et al.. (2022). The role of antigen-presenting cells in the pathogenesis of COVID-19. Pathology - Research and Practice. 233. 153848–153848. 20 indexed citations
19.
Aghbash, Parisa Shiri, et al.. (2021). SARS-CoV-2 infection: The role of PD-1/PD-L1 and CTLA-4 axis. Life Sciences. 270. 119124–119124. 60 indexed citations
20.
Aghbash, Parisa Shiri, Nima Hemmat, Javid Sadri Nahand, et al.. (2021). The role of Th17 cells in viral infections. International Immunopharmacology. 91. 107331–107331. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Santhamani Ramasamy Breakdown of academic impact, for papers by Alireza Tabibzadeh Breakdown of academic impact, for papers by Yan‐Mei Jiao Breakdown of academic impact, for papers by Vasiliki Triantafyllia Breakdown of academic impact, for papers by Uffe Vest Schneider Breakdown of academic impact, for papers by Paulina Nowak Breakdown of academic impact, for papers by Anping Ni Breakdown of academic impact, for papers by Mario Tönnies Breakdown of academic impact, for papers by Céline Pellaton Breakdown of academic impact, for papers by Juliana Gil Melgaço
Rankless by CCL
2026